Previous/Concurrent Radiation Enhanced the Response of Toripalimab in Advanced and Recurrent Liver Cancer: A Pilot Study

B Chen, Y R Zhai,Y X Li,L Wang, J Wu, S L Wang, L Niu, H Zeng,F Wu大牛学者, W Rong,Y Song, Y Sun,T Yu,Y Tang,N Li, H Fang, Z Yang, P Zhao,Y Liu大牛学者,Y W Song, N N Lu,H Jing, S N Qi,Y Yang

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS（2021）

引用 1|浏览6

暂无评分

摘要

For patients with advanced or recurrent liver cancer, toripalimab in combination with concurrent or previous radiotherapy is an effective treatment with tolerable toxicities. A prospective trial with large number of patients is warranted.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络